Xiang Cai1, Jaclyn M W Hughto2,3,4, Sari L Reisner5,6,7,8, John E Pachankis1, Becca R Levy1,9. 1. 1 Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, Connecticut. 2. 2 Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island. 3. 3 Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island. 4. 4 Center for Health Equity Research, Brown University School of Public Health, Providence, Rhode Island. 5. 5 Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. 6. 6 Department of Epidemiology, Harvard T.H Chan School of Public Health, Boston, Massachusetts. 7. 7 Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. 8. 8 The Fenway Institute, Fenway Health, Boston, Massachusetts. 9. 9 Department of Psychology, Yale University, New Haven, Connecticut.
Abstract
PURPOSE: This study examined whether older age moderates the association between gender-affirming medical treatment and quality of life (QOL) among transgender individuals. METHODS: Transgender men and women from the National Transgender Discrimination Survey who had either recently or never undergone medical treatment were included (n = 2420). A moderation analysis was utilized. RESULTS: As predicted, participants who initiated medical treatment had higher QOL than those who did not. Age moderated this association. The QOL difference was greater for older than for younger transgender individuals. CONCLUSION: Among all transgender men and women, gender-affirming medical treatment can be especially beneficial for elders.
PURPOSE: This study examined whether older age moderates the association between gender-affirming medical treatment and quality of life (QOL) among transgender individuals. METHODS: Transgender men and women from the National Transgender Discrimination Survey who had either recently or never undergone medical treatment were included (n = 2420). A moderation analysis was utilized. RESULTS: As predicted, participants who initiated medical treatment had higher QOL than those who did not. Age moderated this association. The QOL difference was greater for older than for younger transgender individuals. CONCLUSION: Among all transgender men and women, gender-affirming medical treatment can be especially beneficial for elders.
Entities:
Keywords:
aging; gender-affirming medical treatment; quality of life; transgender
Authors: Karen I Fredriksen-Goldsen; Loree Cook-Daniels; Hyun-Jun Kim; Elena A Erosheva; Charles A Emlet; Charles P Hoy-Ellis; Jayn Goldsen; Anna Muraco Journal: Gerontologist Date: 2013-03-27
Authors: Kimberly A Skarupski; Carlos F Mendes de Leon; Julia L Bienias; Paul A Scherr; Matthew M Zack; David G Moriarty; Denis A Evans Journal: Qual Life Res Date: 2006-10-11 Impact factor: 3.440
Authors: Daphna Stroumsa; Halley P Crissman; Vanessa K Dalton; Giselle Kolenic; Caroline R Richardson Journal: Ann Fam Med Date: 2020-11 Impact factor: 5.166
Authors: E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus Journal: Int J Transgend Health Date: 2022-09-06